U.S. Mortgage REITs Stock News

Nuclear energy stocks sit at the crossroads of two powerful forces. Investors are watching inflation, central bank moves and energy prices very closely, while governments still want reliable, low carbon power. The Nuclear Energy Stocks screener filters this complex backdrop into a focused list of companies involved in uranium production, fuel services and reactor projects, so you spend less time sorting and more time assessing. This article highlights 3 stocks from that screener that stand...

ProPetro Holding Corp. has reported past half-year results for the period ended June 30, 2026, posting a net loss of US$8.11 million, slightly higher than the US$7.16 million loss in the same period a year earlier, with basic and diluted losses per share unchanged at US$0.07. The stability in per-share losses despite a larger overall net loss raises questions about how shifts in share count, cost structure, or mix of operations may be affecting shareholder outcomes. Against this backdrop of...

Pediatrix Medical Group dropped almost 6% today, yet the headline from this quarter is not a collapse in profit. The stock came into the print already soft over the past month, then sold off again even as Q2 basic EPS reached about US$0.50 and revenue sat near US$488 million. The market is fixated on near term worries around pricing tailwinds and volumes. The numbers tell a more nuanced story of a physician services business wrestling with sentiment while margins and earnings trend in a...

Rhythm Pharmaceuticals stock closed up 2.9% at US$105.78, a sharp intraday vote of confidence after a choppy month that left the shares down about 7% over 30 days. The move came as investors digested a Q2 report that paired rapid revenue expansion with continued losses, a familiar trade off in high growth biotech. The headline this quarter is clear. Global net product sales reached US$71.3 million, powered by early demand for IMCIVREE in acquired hypothalamic obesity, while the company still...

BRC stock walked into this earnings print treading water. The share price has gone nowhere on the day at about US$1.05, even after a year that left holders facing double digit declines. The business story looks very different. Black Rifle Coffee Company just put up roughly US$107 million of Q2 revenue and turned in positive free cash flow of about US$5.4 million. Gross margin edged into the mid 30s and adjusted EBITDA reached about US$6.3 million. For a company still working through losses,...

Sterling Infrastructure stock just dropped 11% to about US$542 after a hot run into earnings, yet the quarter was anything but cold. The company posted Q2 revenue of US$1.17b and basic earnings per share of US$5.08, powered by a surge in high margin E Infrastructure projects. That clash between a sharp price pullback and robust reported growth sets up a clear time horizon choice for you: focus on today’s volatility or on a business now carrying a US$4.3b signed backlog and multi year project...

Advanced Micro Devices stock has delivered a very strong run over the past few years, while the current valuation signals are pulling in different directions. The Discounted Cash Flow (DCF) intrinsic value estimate points to a premium to today’s price, while earnings based multiples suggest the stock may still be on the cheap side. Over the last 5 years, Advanced Micro Devices has returned about 3.9x, which sets a high bar for any further upside to be justified by fundamentals. Large AI...

Inspire Medical Systems stunned the market today. The stock jumped about 23% to US$64.14 after earnings, extending strong recent gains, even though Q2 revenue sat at US$200.6m and slipped against last year as coding and reimbursement issues weighed on implant volumes. The real story sits on a longer clock. Inspire Medical Systems turned a small quarterly profit of roughly US$0.01 per share and delivered positive operating cash flow while revenue pressure remained, then paired that with a...

JELD-WEN Holding stock jumped about 26% today, a sharp swing for a company that has been trading under the weight of deep losses and balance sheet stress. The move reflects relief more than euphoria. The headline is that JELD-WEN finally put up a cleaner quarter, with Q2 revenue of about US$818 million and adjusted EBITDA of US$42 million, while still reporting a net loss. Investors are reacting to signs that the margin story is starting to improve, even though the profit and leverage issues...

Leidos Holdings entered this quarter with a value profile and a flat three month share price, then surprised the market with a 10% jump to about US$130.60 once investors saw the numbers. The company delivered Basic EPS of US$2.81 on revenue of US$4.56b, alongside record operating cash flow, which gave investors in this defense and government technology contractor specific results to reprice. The stock now reflects a sudden reset of expectations that were not fully captured in the modest...

Whirlpool stock ripped higher, jumping 13.8% to US$44.62, as investors grabbed for a quick rebound story in a company that has spent the last year grinding through profit pressure and balance sheet fixes. The headline this quarter is margin, not sales. Management delivered a slim 1.8% ongoing operating margin on about US$3.5b of Q2 revenue and still expects only about 4% for the full year. For a global appliance manufacturer with heavy debt and rising interest costs, that kind of margin...

Bank OZK (OZK) has drawn fresh attention after its recent share price moved around current valuations, with the stock closing at $52.24. Investors are examining how this development relates to the bank’s broader fundamentals. See our latest analysis for Bank OZK. Over the past year, Bank OZK has combined a 11.05% year to date share price return with a 11.45% 1 year total shareholder return, while its 3 year and 5 year total shareholder returns of 35.41% and 45.80% hint at gradually building...

Why Alignment Healthcare’s latest earnings matter for investors Alignment Healthcare (ALHC) has drawn fresh attention after reporting second quarter 2026 results and updating its revenue outlook, putting recent stock volatility and ongoing legal investigations into sharper focus for investors. See our latest analysis for Alignment Healthcare. Despite stronger recent earnings and higher guidance, Alignment Healthcare’s share price has come under heavy pressure, with a 30 day share price return...

Everest Group stock barely flinched after earnings, slipping about 0.8% to roughly US$369 and leaving the 7 day move only modestly in the red. That calm surface hides a stronger story. The insurer just posted quarterly basic earnings per share of US$14.23 on US$4.0b in revenue with a combined ratio of 92%. For a property and casualty player, that underwriting result is the headline. The market looks more hesitant than impressed, which raises a clear question for investors about whether short...

Why Principal Financial Group Stock Is Back on Investor Radars Principal Financial Group (PFG) has drawn fresh attention after reporting second quarter 2026 results that showed higher revenue, broadly steady net income, and slightly higher earnings per share compared with a year earlier. See our latest analysis for Principal Financial Group. Principal Financial Group’s share price has gained 3.9% over the past month and 28.9% year to date, while the 1 year total shareholder return of 56.9%...

Record highs for the S&P 500 and Dow, softer Treasury yields and sharp moves in oil and tech are reshaping where dividend growth stocks may fit in a portfolio. With corporate earnings surprising to the upside and AI linked tech stocks back in focus, investors looking for growing income streams now have a fresh backdrop to consider. This article walks through 3 dividend growth stocks from our screener that appear closely tied to these market drivers. The goal is to help you decide whether...

Zimmer Biomet’s recently reported second-quarter results highlighted ongoing strength in its hip triple-play and knee portfolios, even as analysts reassessed the company’s muted revenue growth and modest 4.2% return on capital in light of its long operating history and global scale. The key tension now is between solid procedural demand in core orthopedics and growing concern that management has limited avenues for highly profitable expansion. Next, we’ll explore how this mix of resilient...

The market wasted no time rewarding AMETEK. The stock jumped 4.2% to US$254.05 in the first session after results, extending a strong run into the print. That kind of move typically occurs when the earnings story aligns with expectations. For AMETEK, the headline is clear. Q2 revenue reached about US$2.0b and net income came in above US$400m, both supported by high margins and strong free cash flow conversion. Traders are reacting to a report that shows demand and profitability in its...

Reservoir Media entered this report with a relatively high P/E and a stock that had drifted slightly over the past month. The first look at Q1 numbers did not spark a rally. Shares slipped about 1% to US$10.06 after the release, even though revenue reached about US$41.5 million and adjusted earnings before interest, tax, depreciation and amortization (EBITDA) was US$15.7 million. The headline is simple: the music catalog story is still growing at the top line, but higher interest costs and a...

Sunoco stock closed at US$74.33, down about 4% on the day, even as the company posted one of its cleanest profit beats in recent quarters. The core story is not the single quarter earnings per share print. The headline is the upgraded full year adjusted earnings before interest, tax, depreciation and amortization guidance to US$3.5b to US$3.7b, backed by almost US$1b of adjusted EBITDA in the quarter. Short term traders focused on the price drop. Long term holders are looking at that higher...

Bancorp (TBBK) has drawn fresh attention after reporting second quarter 2026 results, updating earnings guidance for 2026 and 2027, detailing lower net charge offs, completing a share repurchase, and receiving affirmed credit ratings. See our latest analysis for Bancorp. The latest earnings update, lower net charge offs, completed buyback and affirmed credit ratings appear to have supported renewed interest in Bancorp, with a 19.16% 90 day share price return and a 5 year total shareholder...

Kimberly-Clark stock shook off a softer recent stretch and jumped 3.7% to US$111.57 in the first full session after Q2 results. That move came after a week and month where the shares had drifted lower, so the market clearly liked something in this report. The headline is profit resilience in a choppy quarter. Q2 basic earnings per share landed at US$1.22 on revenue of US$4.19b, with net income from ongoing operations at US$405m despite issues like China diaper disruption and North America...

Viemed Healthcare stock just took a heavy hit, dropping almost 16% to about US$9.84, even though the latest quarter showed revenue of US$78.1m and basic earnings per share of roughly US$0.07. The market is clearly trading the headline move rather than the longer story. Step back from today’s red screen and a different picture starts to form. On a trailing basis Viemed Healthcare is earning about US$0.38 per share, carries a P/E of 25.8x, and is trading well below one discounted cash flow...

The market cheered Arvinas with an 11.7% jump to about $9, yet the real headline sits in the income statement. A biotech that many investors still file mentally under early stage clinical story just printed Q2 basic earnings per share of $2.61 on revenue of $249.7m, driven by licensing and collaboration flows. Coming into the release, the stock had drifted over the past three months, with a weaker 90 day return despite modest gains in the last week and month. Today's move is the market trying...